Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}} Now: 1770469961758 Cache Key: cqdTagPageBySlug:aflibercept fetchCache[cqdTagPageBySlug:aflibercept].expirationTime: falsey fetchCache[cqdTagPageBySlug:aflibercept]. seconds remaining: falsey All fetchCache expiration times: -- Key: cqdNotFoundPage, seconds remaining: 9485 -- Key: cqdTagPageBySlug:endoscopic-mucosal-resection, seconds remaining: -3018 -- Key: cqdPostsByTag:cqd-migrated-tag-20643,1,10, seconds remaining: -2945 -- Key: cqdTagPageBySlug:paul-ford, seconds remaining: -2480 -- Key: cqdPostsByTag:cqd-migrated-tag-1689,1,10, seconds remaining: -2415 -- Key: cqdTagPageBySlug:tenecteplase-tnk, seconds remaining: -1407 -- Key: cqdPostsByTag:cqd-migrated-tag-24348,1,10, seconds remaining: -1344 -- Key: cqdTagPageBySlug:tooth-loss, seconds remaining: -745 -- Key: cqdPostsByTag:cqd-migrated-tag-22962,1,10, seconds remaining: -669 -- Key: cqdTagPageBySlug:substance-abuse, seconds remaining: -316 -- Key: cqdPostsByTag:cqd-migrated-tag-20822,1,10, seconds remaining: -248 -- Key: cqdTagPageBySlug:patient-satisfaction, seconds remaining: 889 -- Key: cqdPostsByTag:cqd-migrated-tag-14155,1,10, seconds remaining: 958 -- Key: cqdTagPageBySlug:machine-learning, seconds remaining: 1808 -- Key: cqdPostsByTag:cqd-migrated-tag-18105,5,10, seconds remaining: 1880 -- Key: cqdTagPageBySlug:todd-francis, seconds remaining: 2990 -- Key: cqdPostsByTag:cqd-migrated-tag-1491,1,10, seconds remaining: 3058 -- Key: cqdTagPageBySlug:adenomatous-polyps, seconds remaining: 5727 -- Key: cqdPostsByTag:cqd-migrated-tag-21650,1,10, seconds remaining: 5796 -- Key: cqdTagPageBySlug:zygote, seconds remaining: 6388 -- Key: cqdPostsByTag:cqd-migrated-tag-20322,1,10, seconds remaining: 6458 -- Key: cqdTagPageBySlug:chronic-cough, seconds remaining: 7823 -- Key: cqdPostsByTag:cqd-migrated-tag-5079,1,10, seconds remaining: 7889 -- Key: cqdTagPageBySlug:amy-lee, seconds remaining: 9485 -- Key: cqdPostsByTag:cqd-migrated-tag-2341,1,10, seconds remaining: 9550 -- Key: cqdTagPageBySlug:research-advice, seconds remaining: 9757 -- Key: cqdPostsByTag:cqd-migrated-tag-4809,1,10, seconds remaining: 9828 conditions: -- false, -- NA, -- NA, -- NA -- false Cache miss for key cqdTagPageBySlug:aflibercept - retrieving from Sanity CCCache.dataFetchCount: 3478 Cache cleanup seconds remaining: 22990
Advertisement
Advertisement
New insights on effectiveness in patients previously treated with other anti-VEGF drugs
Switching medications may decrease treatment burden and macular fluid
Greater central subfield thickness and better visual acuity at baseline are associated with longer time to resolution
Faricimab every 16 weeks offers similar benefits as aflibercept every eight weeks
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Rendered: Sat Feb 07 2026 13:12:42 GMT+0000 (Coordinated Universal Time)
9500 Euclid Avenue, Cleveland, Ohio 44195 |
800.223.2273 | ©
2026 Cleveland Clinic. All Rights Reserved.